# Dose Finding, Safety and Tolerability Study for AC220 to Treat Advanced Solid Tumors

> **NCT01049893** · PHASE1 · COMPLETED · sponsor: **Daiichi Sankyo** · enrollment: 45 (actual)

## Conditions studied

- Solid Tumors

## Interventions

- **DRUG:** Compound AC220

## Key facts

- **NCT ID:** NCT01049893
- **Lead sponsor:** Daiichi Sankyo
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-01
- **Primary completion:** 2011-11
- **Final completion:** 2011-11
- **Target enrollment:** 45 (ACTUAL)
- **Last updated:** 2019-02-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01049893

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01049893, "Dose Finding, Safety and Tolerability Study for AC220 to Treat Advanced Solid Tumors". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01049893. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*